INCYTE CORPORATION

ZYNYZ

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / ZYNYZ – J9345

Manufacturer:

INCYTE CORPORATION

Name:

ZYNYZ

HCPCS Code Descriptor:

Injection, retifanlimab-dlwr, 1 mg

Category:

J Code

HCPCS:

J9345

NDC(s):

50881-0006-03

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

ZYNYZ is an Oncology drug manufactured by Incyte and administered via the Intravenous route of administration. The J Code: J9345 is aligned to the drug ZYNYZ.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

10/1/23

HCPCS Effective Date:

10/1/23

HCPCS Short Description:

Inj, retifanlimab-dlwr, 1 mg

Billing and Coding Guide:

Patient Assistance:

https://www.incytecares.com/